Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Livio

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
The American Journal of Physiology|June 1, 1988
Role of platelet-activating factor in primary hemostasisM Livio, G Vigano, M Morigi, et al.
Prostaglandins, Leukotrienes, and Medicine|March 1, 1982
Salicylate interferes in vivo with aspirin-induced inhibition of platelet and vascular prostaglandin generation in ratsC Cerletti, M Livio, C de Castellarnau, et al.
The Journal of Clinical Investigation|June 1, 1987
Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibitionF Gaspari, G Viganò, S Orisio, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1985
Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolismD Macconi, G Morzenti, M Livio, et al.
Lancet (London, England)|November 6, 1982
Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusionsM Livio, E Gotti, D Marchesi, et al.
Lancet (London, England)|March 28, 1981
Thrombotic tendency in systemic lupus erythematosusD Marchesi, A Parbtani, G Frampton, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritisM Livio, D Macconi, M Morigi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1992
Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generationD Macconi, G Viganò, G Bisogno, et al.
Thrombosis and Haemostasis|August 31, 1977
Possible role of HLA-B8 antigen as a genetic marker of autoimmune thrombocytopenia in a patient with myasthenia gravisG Remuzzi, R Misiani, M Livio, et al.
Kidney International|June 1, 1987
Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritisT Bertani, M Livio, D Macconi, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
The American Journal of Physiology|June 1, 1988
Role of platelet-activating factor in primary hemostasisM Livio, G Vigano, M Morigi, et al.
Prostaglandins, Leukotrienes, and Medicine|March 1, 1982
Salicylate interferes in vivo with aspirin-induced inhibition of platelet and vascular prostaglandin generation in ratsC Cerletti, M Livio, C de Castellarnau, et al.
The Journal of Clinical Investigation|June 1, 1987
Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibitionF Gaspari, G Viganò, S Orisio, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1985
Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolismD Macconi, G Morzenti, M Livio, et al.
Lancet (London, England)|November 6, 1982
Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusionsM Livio, E Gotti, D Marchesi, et al.
Lancet (London, England)|March 28, 1981
Thrombotic tendency in systemic lupus erythematosusD Marchesi, A Parbtani, G Frampton, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritisM Livio, D Macconi, M Morigi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1992
Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generationD Macconi, G Viganò, G Bisogno, et al.
Thrombosis and Haemostasis|August 31, 1977
Possible role of HLA-B8 antigen as a genetic marker of autoimmune thrombocytopenia in a patient with myasthenia gravisG Remuzzi, R Misiani, M Livio, et al.
Kidney International|June 1, 1987
Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritisT Bertani, M Livio, D Macconi, et al.
Pageof 7